Cystic Fibrosis Foundation Inc entered the industry of Medical Research in 0 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 6241901, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.
To acquire more information, please contact David Compton, Executive Director by calling (315) 463-7965 during business hours. You can also write to the business’ Single Location at 2507 James St, Syracuse, New York NY 13206. You can also visit the company’s website at cff.org. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Cystic Fibrosis Foundation Inc |
| Representative: | David Compton, Executive Director |
| Place of Business: | 2507 James St, Syracuse, NY 13206 |
| Contact Number: | (315) 463-7965 |
| Website: | cff.org |
| Type of Service: | Medical Research |
| SIC Number: | 8733 |
| NAICS Number: | 6241901 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Income/Year: | Unknown |
| Laborers: | 1 to 4 |
| Share This Company: |
Cystic Fibrosis Foundation Inc is a company operating from Onondaga, New York providing professional Medical Research and relevant B2B variables. It was founded in 0 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 6241901 as Medical Research.
With a current employee count of 1 to 4, Cystic Fibrosis Foundation Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative David Compton, Executive Director at (315) 463-7965 for related queries, or to locate its Single Location using the coordinates 43.06863,-76.11165.
The Single Location can also be found at the street address 2507 James St in Syracuse, New York 13206 and can be engaged online through the company website at cff.org, the company Twitter , and Facebook page .